Digipath Financial Statements From 2010 to 2024
| DIGPDelisted Stock | USD 0.03 0 3.70% |
Check Digipath financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Digipath's main balance sheet or income statement drivers, such as , as well as many indicators such as . Digipath financial statements analysis is a perfect complement when working with Digipath Valuation or Volatility modules.
Digipath |
Digipath Company Operating Margin Analysis
Digipath's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Digipath Operating Margin | (0.38) % |
Most of Digipath's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Digipath is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Digipath has an Operating Margin of -0.3757%. This is 98.93% lower than that of the Health Care Providers & Services sector and 99.41% lower than that of the Health Care industry. The operating margin for all United States stocks is 93.18% lower than that of the firm.
Digipath Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Digipath's current stock value. Our valuation model uses many indicators to compare Digipath value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Digipath competition to find correlations between indicators driving Digipath's intrinsic value. More Info.Digipath is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Digipath's earnings, one of the primary drivers of an investment's value.About Digipath Financial Statements
Digipath shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Digipath investors may analyze each financial statement separately, they are all interrelated. The changes in Digipath's assets and liabilities, for example, are also reflected in the revenues and expenses on on Digipath's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Digipath, Inc., together with its subsidiaries, provides cannabis and hemp lab testing services in Las Vegas to Nevada licensed medical marijuana enterprises. Digipath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada. Digipath operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 17 people.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Digipath Pink Sheet
If you are still planning to invest in Digipath check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Digipath's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |